VIGIL NEUROSCIENCE INC's ticker is and the CUSIP is 92673K108. A total of 36 filers reported holding VIGIL NEUROSCIENCE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,419,522 | -42.7% | 448,891 | 0.0% | 0.05% | -32.9% |
| Q2 2023 | $4,219,575 | -4.0% | 448,891 | 0.0% | 0.08% | -11.6% |
| Q1 2023 | $4,394,643 | -21.7% | 448,891 | 0.0% | 0.09% | -19.6% |
| Q4 2022 | $5,611,138 | +50.0% | 448,891 | +9.2% | 0.11% | +55.1% |
| Q3 2022 | $3,742,000 | +252.7% | 411,191 | 0.0% | 0.07% | +263.2% |
| Q2 2022 | $1,061,000 | -63.3% | 411,191 | 0.0% | 0.02% | -59.6% |
| Q1 2022 | $2,891,000 | – | 411,191 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 4,214,498 | $22,716,144 | 65.40% |
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $31,460,750 | 4.87% |
| Trustees of Columbia University in the City of New York | 192,973 | $1,040,124 | 1.91% |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $3,021,607 | 1.20% |
| Artal Group S.A. | 1,908,135 | $10,285 | 0.44% |
| Deep Track Capital, LP | 1,767,131 | $9,524,836 | 0.37% |
| DAFNA Capital Management LLC | 172,308 | $928,740 | 0.29% |
| BVF INC/IL | 1,813,633 | $9,775,482 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,827,400 | $9,849,686 | 0.22% |
| Cormorant Asset Management, LP | 616,786 | $3,324,477 | 0.19% |